Abstract: An electric submersible pump system for use in a wellbore includes a pump; a motor protection component having an oil chamber and an wellbore fluid chamber; a motor component, the motor component including oil and being fluidly coupled to the oil chamber of the motor protection component; and a chemical chamber that includes a neutralization chemical. The neutralization chemical includes a scale inhibitor. The chemical chamber is configured to contact fluid from the wellbore with the neutralization chemical and is fluidly coupled to the wellbore fluid chamber of the motor protection component. The pump is configured to be driven by the motor component. A chemical chamber and a method for operating an electric submersible pump are also disclosed.

Abstract: Automated vending system for pre-ordered custom-prepared food packages comprises a kiosk for housing a plurality of custom-prepared food packages, each custom-prepared food package associated with a specific order received from a customer, the plurality of custom-prepared food packages positioned in a storage rack within the kiosk. If further includes a robotic arm located within the kiosk, the robotic arm configured to engage a first food package from the storage rack and deliver the first food package to a product delivery area of the kiosk. It also includes a user interface configured for receiving a user selection of the first food package, and a controller configured to command the robotic arm to select and deliver the first food package to the product delivery area.

Abstract: Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

Abstract: A mop includes a mop head, a secondary cleaning head and a handle. The mop head includes a secondary cleaning head chamber and a first attachment element. The secondary cleaning head is selectively receivable in the secondary cleaning head chamber and includes a second attachment element that cooperates with the first attachment element to selectively connect the secondary cleaning head with the mop head. The handle connects with the secondary cleaning head and is operatively connectable to the mop head. The handle is connected with the mop head when the secondary cleaning head is received in the secondary cleaning head chamber and the second attachment element is engaged with the first attachment element, and the handle is disconnected with the mop head when the secondary cleaning head is not received in the secondary cleaning head chamber.

Abstract: Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

Abstract: Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

Abstract: Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

Abstract: A mop includes a mop head, a secondary cleaning head and a handle. The mop head includes a secondary cleaning head chamber and a first attachment element. The secondary cleaning head is selectively receivable in the secondary cleaning head chamber and includes a second attachment element that cooperates with the first attachment element to selectively connect the secondary cleaning head with the mop head. The handle connects with the secondary cleaning head and is operatively connectable to the mop head. The handle is connected with the mop head when the secondary cleaning head is received in the secondary cleaning head chamber and the second attachment element is engaged with the first attachment element, and the handle is disconnected with the mop head when the secondary cleaning head is not received in the secondary cleaning head chamber.

Abstract: Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

Abstract: Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

Abstract: Antigen binding proteins that bind to human GM-CSF protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of GM-CSF to GM-CSFR, inhibit GM-CSF-induced proliferation and signaling of myeloid lineage cell lines and inhibit GM-CSF-induced activation of human monocytes.

Abstract: Antigen binding proteins that bind to human GM-CSF protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of GM-CSF to GM-CSFR, inhibit GM-CSF-induced proliferation and signaling of myeloid lineage cell lines and inhibit GM-CSF-induced activation of human monocytes.

Abstract: Antigen binding proteins that bind to human GM-CSF protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of GM-CSF to GM-CSFR, inhibit GM-CSF-induced proliferation and signaling of myeloid lineage cell lines and inhibit GM-CSF-induced activation of human monocytes.

Abstract: Antigen binding proteins that bind to human GM-CSF protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of GM-CSF to GM-CSFR, inhibit GM-CSF-induced proliferation and signaling of myeloid lineage cell lines and inhibit GM-CSF-induced activation of human monocytes.

Abstract: Antigen binding proteins that bind to human GM-CSF protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of GM-CSF to GM-CSFR, inhibit GM-CSF-induced proliferation and signaling of myeloid lineage cell lines and inhibit GM-CSF-induced activation of human monocytes.

Abstract: A method system, interface and server for establishing a communications call by selecting a B party (6) using an interactive device (16) connected to a public network (10,12), sending called address data for the B party (6) and calling address data for an A party (4) to a communications platform (18) of the public network (10,12), and establishing a call between the A and B parties (4,6) over the public network (10,12) using the communications platform (18) and the called and calling address data. The called address data can be accessed from the public network, and may reside on a server of a messaging network, such as the Internet.

Abstract: A method system, interface and server for establishing a communications call by selecting a B party (6) using an interactive device (16) connected to a public network (10,12), sending called address data for the B party (6) and calling address data for an A party (4) to a communications platform (18) of the public network (10,12), and establishing a call between the A and B parties (4,6) over the public network (10,12) using the communications platform (18) and the called and calling address data. The called address data can be accessed from the public network, and may reside on a server of a messaging network, such as the Internet.

Abstract: A trash can is disclosed having an exterior shell, a liner seated within the shell, a latch pivotably attached to the liner for securing a flexible bag to the liner, and a handle to facilitate placing and removing of the liner from the shell. An optional aspect of the invention is to affix the handle of the liner to the latch. The liner of the trash can, in a featured embodiment, utilizes a latch having a body portion into which surplus of the flexible bag may be gathered and held. The trash can may further include a lid connected to the exterior shell. The lid connects to the shell using a front hinge and a back hinge and is actuated by a foot pedal. The actuating foot pedal is preferably seated at a base of the exterior shell and connects to the lever arm of the front hinge such that depressing the foot pedal exerts a downward force on the lever arm to open the lid. In this configuration, the lid is lifted via a downward pull on the first hinge rather than a direct upward force on the lid.

Abstract: An ergonomic handle for use with a hand tool, such as a pair of scissors or the like, is disclosed which includes first and second opposing lever members coupled together at a pivot point to permit reciprocating movement of the lever members between a closed position and an open position. The lever members may include a cutting blade or other tool feature on a first end adjacent the pivot point, and a handle on a second end adjacent the pivot point opposite the first end. The fixed handle has a loop portion which includes an inner surface and an outer surface along one side of which abuts a corresponding outer surface of the opposing lever member while in the closed position. Each loop portion is made from a rigid material segment and a resilient material segment, with the rigid material segment having a cavity open at the outer loop surface and the resilient material segment extending across the cavity at the inner loop surface.

Abstract: A method system, interface and server for establishing a communications call by selecting a B party (6) using an interactive device (16) connected to a public network (10,12), sending called address data for the B party (6) and calling address data for an A party (4) to a communications platform (18) of the public network (10,12), and establishing a call between the A and B parties (4,6) over the public network (10,12) using the communications platform (18) and the called and calling address data. The called address data can be accessed from the public network, and may reside on a server of a messaging network, such as the Internet.